{
  "ticker": "RHY",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976389",
  "id": "02976389",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250804",
  "time": "0911",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250804/pdf/06mhdpvjg4ds7w.pdf",
  "summary": "### Summary of Material Information:  \n- **Product Milestone**: Final production validation stage of ColoSTAT\u00ae kits completed, with high-quality kits received for internal testing.  \n- **Clinical Performance**: ColoSTAT\u00ae demonstrates consistent diagnostic accuracy across all colorectal cancer stages (I\u2013IV), meeting requirements for symptomatic patient testing.  \n- **Regulatory Path**: Final validation and NATA submission pending, with commercial launch targeted for CY2025 (subject to approval).  \n\n*Note: No capital markets actions (e.g., raising, trading halt) or financial data disclosed.*",
  "usage": {
    "prompt_tokens": 1329,
    "completion_tokens": 116,
    "total_tokens": 1445,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-03T23:19:05.728836"
}